《巨乳人妻》无删减电影,巜饥渴的人妻日本》中字,四个人妻互换不戴套,公玩弄年轻人妻HD,人人妻人人澡人人爽人人DVD,漂亮人妻洗澡被强公BD

BioDetect Brand Rapid SARS-CoV-2 Antigen Test Card (Colloidal gold method) were approved for China local Market!

Column:Company News Time:2023-08-10
On August 10, 2023, BioDetect Rapid SARS-CoV-2 Antigen Test Card (Colloidal gold method) was registered and approved by the State Food and Drug Administration.

        On August 10, 2023, BioDetect Rapid SARS-CoV-2 Antigen Test Card (Colloidal gold method) was registered and approved by the State Food and Drug Administration, registration number: Guoxiezhuzhun 20233401116. The product is suitable for in vitro qualitative detection of novel coronavirus (2019-nCov) N antigen in nasal swab samples, and has good detection effect on both the original strain and the variant strains of concern (VOC) including Omicron.

 

Product advantages: Simple and Convenient, Instant detection, 15min results, easy to use, safe and reliable.

         In combination with the technical strength of Xiamen University, the R&D team of BioDect Company has developed products such as Rapid Sars-CoV-2 Antigen Test Card, nucleic acid extraction and purification reagent and sample release agent. Relying on the stability of the products, it has won a good market reputation. Among them, the disposable virus sampling tube obtained CE certification and passed the FDA registration; The rapid Sars-CoV-2 antigen test has obtained CE1434, Thailand FDA and Malaysia MDA certification, and has obtained registration and entry permits in Germany BfArm, France ANSM, Italy AIFA, Spain AEMPS and Austria BASG. In July 2022, Boditai's Rapid Sars-CoV-2 Antigen Test Card was included in the EU Common list by the European Commission for Public Safety and listed as A Class A product.At the same time, relying on the technical strength of Xiamen University, we focus on the innovative "gene editing technology-mediated microfluidic chip" for rapid genetic diagnosis.

        Biodetect (Xiamen) Biotechnology Co., Ltd. was founded by the overseas doctor team on July 04, 2017, specializing in the development and production of in vitro diagnostic reagents, and was selected as the leading entrepreneurial talent project of Xiamen "Double Hundred Plan" in 2017. The company is headquartered in Xiamen Biopharmaceutic Industrial Park, a national incubation base. The core technical team brings together a number of postdocs, doctors and overseas returnees. Academicians of the Chinese Academy of Sciences and experts of the "Thousand Talents Plan" serve as technical advisers.




绥化市| 金川县| 松阳县| 宜川县| 石楼县| 福鼎市| 星子县| 阜新市| 三门峡市| 横峰县| 武清区| 称多县| 安义县| 龙陵县| 崇义县| 密云县| 若尔盖县| 东乌珠穆沁旗| 大名县| 华安县| 韶关市| 乌恰县| 廊坊市| 湖口县| 鞍山市| 孟村| 新绛县| 武山县| 饶阳县| 深泽县| 大关县| 蕲春县| 太仓市| 凌海市| 万源市| 湖州市| 汶川县| 宜君县| 莱芜市| 资中县| 探索|